Prader-Willi Syndrome Clinical Trial
Official title:
Chronic Stress, Cognition, and Food Cue Reactivity in Prader-Willi Syndrome: A Magnetoencephalography Study
NCT number | NCT04032639 |
Other study ID # | 1000061983 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | May 30, 2019 |
Est. completion date | May 2024 |
Individuals with Prader-Willi Syndrome (PWS) have increased hunger and food seeking behaviour, as well as learning (cognitive) challenges. In addition, some patients with PW been shown to have low cortisol production, particularly in stressful situations. However, research examining how hormonal, cognitive, and psychological factors are interrelated PWS is limited. To address this gap in knowledge, the goal of this project is to understand how changes in brain regions involved in controlling food intake and cognitive processes are related to changes in hormones regulating appetite, the stress hormone cortisol, and performance on neuropsychological tests.
Status | Recruiting |
Enrollment | 48 |
Est. completion date | May 2024 |
Est. primary completion date | May 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 7 Years to 16 Years |
Eligibility | Inclusion Criteria: - Genetically diagnosed PWS (study population) - Adolescents matched for age, sex, and BMI-percentile (controls) Exclusion Criteria: - Past or current history of alcoholism or consistent drug use - Current untreated major psychiatric illness as defined by the DSM-V criteria - Medications that decrease alertness (that cannot be held on the days of testing) - History of recent major head trauma - Current pregnancy - Diagnosis of diabetes - Current or recent smoker (i.e. >2 cigarettes/week during past year) - History of metal in body (shrapnel, metal slivers, unremovable metal adornments, clips, top braces, pacemaker) - Use of glucocorticoid medications |
Country | Name | City | State |
---|---|---|---|
Canada | The Hospital for Sick Children | Toronto | Ontario |
Canada | The Hospital for Sick Children | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
The Hospital for Sick Children | Holland Bloorview Kids Rehabilitation Hospital, University of Western Ontario, Canada |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Relationships between neuropsychological function and neuronal activity during the food cue reactivity task | To compare how neuropsychological function correlate with neuronal activity in PWS compared to controls | 2 years | |
Other | Relationships between neuropsychological function and neuronal activity during the response inhibition task | To compare how neuropsychological function correlate with neuronal activity in PWS compared to controls | 2 years | |
Primary | Neuronal activity during the food cue reactivity task | To compare neuronal activity between PWS and controls during the food cue task | 2 years | |
Secondary | Relationships between appetite hormone response and neuronal activity during the food cue task | To compare how appetite hormones correlate with neuronal activity in PWS compared to controls | 2 years | |
Secondary | Relationships between cortisol and neuronal activity during the food cue reactivity task | To compare how stress correlates with neuronal activity in PWS compared to controls | 2 years | |
Secondary | Neuronal activity during the emotional processing task | To compare neuronal activity between PWS and controls during the emotional processing task | 2 years | |
Secondary | Neuronal activity during resting state | To compare neuronal activity between PWS and controls during resting state | 2 years | |
Secondary | Neuronal activity during the response inhibition task | To compare neuronal activity between PWS and controls during the response inhibition task | 2 years | |
Secondary | Relationships between neuropsychological function and neuronal activity during the emotional processing task | To compare how neuropsychological function correlate with neuronal activity in PWS compared to controls | 2 years | |
Secondary | Relationships between cortisol and neuronal activity during the emotional processing task | To compare how stress correlates with neuronal activity in PWS compared to controls | 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05032326 -
Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial
|
Phase 3 | |
Completed |
NCT04526379 -
Study of Emotion and Cognition Abilities of Children With PWS and Proposition of an Innovative Remediation
|
N/A | |
Terminated |
NCT03458416 -
A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi Syndrome
|
Phase 2 | |
Completed |
NCT03718416 -
Natural History Study of Serious Medical Events in PWS
|
||
Completed |
NCT05322096 -
Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome
|
Phase 2 | |
Completed |
NCT02205450 -
Growth Hormone in Children Under 2 Years With Prader-Willi in Hospital of Sabadell
|
||
Terminated |
NCT02179151 -
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
|
Phase 3 | |
Completed |
NCT00375089 -
Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity
|
N/A | |
Completed |
NCT00004351 -
Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes
|
N/A | |
Recruiting |
NCT05938543 -
Cerebellar TMS and Satiety in Prader-Willi Syndrome
|
N/A | |
Suspended |
NCT05879614 -
An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)
|
Phase 2 | |
Recruiting |
NCT03031626 -
Oxygen Versus Medical Air for Treatment of CSA in Prader Will Syndrome
|
Phase 4 | |
Withdrawn |
NCT04086810 -
An Open-Label Study of DCCR Tablet in Patients With PWS
|
Phase 3 | |
Completed |
NCT02629991 -
Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
|
Phase 2 | |
Recruiting |
NCT02297022 -
Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome
|
Phase 1 | |
Not yet recruiting |
NCT02263781 -
PREPL in Health and Disease
|
N/A | |
Completed |
NCT00551343 -
Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome
|
N/A | |
Recruiting |
NCT06448871 -
Ultrasound to Assess Sarcopenia in Prader Willi Syndrome
|
||
Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
Recruiting |
NCT05939453 -
Impact of Bright Light Therapy on Prader-Willi Syndrome
|
N/A |